Novartis India Ltd. - Research Center
500672 NOVARTIND Group (B) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
12.34 |
12.34 |
12.34 |
12.34 |
12.34 |
Share application money
Preference share capital
Reserves & surplus
763.32 |
681.58 |
701.80 |
708.39 |
746.85 |
Secured loans
Unsecured loans
Total
775.66 |
691.70 |
711.19 |
720.73 |
759.19 |
Gross block
26.85 |
32.94 |
74.81 |
85.08 |
23.93 |
Less : revaluation reserve
Less : accumulated depreciation
7.60 |
9.29 |
10.90 |
8.80 |
8.95 |
Net block
19.25 |
23.65 |
63.91 |
76.28 |
14.98 |
Capital work-in-progress
Investments
Current assets, loans & advances
963.69 |
933.92 |
938.38 |
1,001.36 |
967.46 |
Less : current liabilities & provisions
207.28 |
265.87 |
291.10 |
356.91 |
223.25 |
Total net current assets
756.41 |
668.05 |
647.28 |
644.45 |
744.21 |
Miscellaneous expenses not written
Total
775.66 |
691.70 |
711.19 |
720.73 |
759.19 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
419.25 |
422.34 |
431.36 |
406.30 |
241.90 |
Number of equity sharesoutstanding (Lacs)
246.91 |
246.91 |
246.91 |
246.91 |
246.91 |